XML 42 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Restatement of Consolidated Financial Statements
12 Months Ended
Dec. 31, 2012
Notes to Financial Statements  
2. Restatement of Consolidated Financial Statements

Background

 

On February 27, 2013, Company management, in consultation with its Audit Committee, revised its prior position on accounting for warrants and concluded that its previously issued consolidated financial statements for all periods since mid-November 2009 (collectively, the “Affected Periods”) should not be relied on because of a misapplication in the guidance on accounting for Warrants (as defined below). The restated consolidated balance sheets only reflect previously reported and restated amounts for “Total liabilities” as “Current liabilities” were not impacted. However, the non-cash adjustments to the financial statements, in all of the Affected Periods, do not impact the amounts previously reported for the Company’s cash and cash equivalents, total assets, revenue, or net cash flows from operating, investing and financing activities.

 

The warrants at issue (collectively, the “Warrants”) include:

 

(i)warrants to purchase an aggregate of 5,522 and 414 shares of the Company’s common stock, issued in November 2009 at an exercise price of $650.00 and $575.00 per share, respectively;

 

(ii)warrants to purchase an aggregate of 10,500 and 630 shares of the Company’s common stock, issued in October 2010 at an exercise price of $300.00 and $312.50 per share, respectively;

 

(iii)warrants to purchase an aggregate of 10,673 and 640 shares of the Company’s common stock, issued in January 2011 at an exercise price of $160.00 and $162.50 per share, respectively;

 

(iv)warrants to purchase an aggregate of 26,628 and 799 shares of the Company’s common stock, issued in October 2011 at an exercise price of $44.80 and $59.13 per share, respectively;

 

(v)warrants to purchase an aggregate of 10,648 and 1,597 shares of the Company’s common stock, issued in February 2012 at an exercise price of $28.00 and $27.00 per share, respectively; and

 

(vi)warrants to purchase an aggregate of 483,657 shares of the Company’s common stock, issued in November 2012 at an exercise price of $6.53 per share;

 

The above warrant shares and exercise prices have been retroactively adjusted to reflect the 2011 and 2012 reverse stock splits.

 

Historically, the Warrants were reflected as a component of equity as opposed to liabilities on the balance sheets and the statements of operations did not include the subsequent non-cash changes in estimated fair value of the Warrants in accordance with Accounting Standards Codification 815, Derivatives and Hedging (“ASC 815”). The Warrant agreements contain a provision for net cash settlement at the option of the holder in the event that there is a fundamental transaction (as contractually defined in the Warrant agreements). The Company had previously conducted in-depth analysis in prior years of its other warrants and concluded that all fundamental transactions were within the control of the Company and thus equity treatment for the warrants was appropriate. However, new insight on derivatives obtained by the Company during the process of analyzing the accounting guidance for the November 2012 warrants prompted the Company to re-assess its prior position.

 

Under the guidance of ASC 815, warrant instruments that could potentially require net cash settlement in the absence of express language precluding such settlement, should be initially classified as derivative liabilities as their estimated fair values, regardless of the likelihood that such instruments will ever be settled in cash. In periods subsequent to issuance, changes in the estimated fair value of the derivative instruments should be reported in the statement of operations. The Audit Committee, together with management, determined that the consolidated financial statements in the Affected Periods should be restated to reflect the Warrants as liabilities, with subsequent changes in their estimated fair value recorded as non-cash income or expense in each Affected Period.

 

The Company has restated its audited consolidated financial statements for the year ending December 31, 2011 and the related disclosures. The Company has not amended its previously filed Annual Reports on Form 10-K for the years ended December 31, 2010 and 2009 or its Quarterly Reports on Form 10-Q for the periods March 31, 2010, June 30, 2010, and September 30, 2010 to correct these misstatements.

 

               The impact of the restatement on the unaudited condensed consolidated statements of operations for the three-month periods ended March 31, June 30, and September 30, 2012 and 2011, and the condensed consolidated balance sheets as of March 31, June 30 and September 30, 2012 and 2011are presented below, as wells as the impact on the consolidated statements of operations for the years ended December 31, 2011, 2010, and 2009, and the consolidated balance sheets then ended. The restatement had no impact on net cash flows from operating, investing or financing activities as the adjustments resulting from the non-cash change in the fair value of the warrant liability for each period and the statements of operations only impacted net income (loss) from continuing operations. In addition to the restatement noted above, the consolidated statements of operations and the consolidated balance sheets have also been retroactively adjusted to give effect to the Company’s September 2012 reverse stock splits, and for the discontinued operations as discussed in note 1 “Summary of Significant Accounting Policies – Nature of Business and Basis of Presentation.”

 

Impact of the Restatement

 

    Three Months Ended March 31, 2012  
    As Previously           As  
Statement of Operations Data (Unaudited):   Reported*     Adjustment     Restated  
Selling, general and administrative expense   $ (674,856 )   $ (17,636 )   $ (692,492 )
Loss from operations   $ (1,046,259 )   $ (17,636 )   $ (1,063,895 )
Other Income from Change in Fair Value of Warrants   $ -     $ 339,308     $ 339,308  
Loss from continuing operations   $ (1,045,237 )   $ 321,672     $ (723,565 )
Net loss   $ (1,155,955 )   $ 321,672     $ (834,283 )
Net loss per share, basic and diluted   $ (6.21 )   $ 1.73     $ (4.48 )

 

    Three Months Ended June 30, 2012  
    As Previously             As  
Statement of Operations Data (Unaudited):   Reported*     Adjustment     Restated  
                         
Selling, general and administrative expense   $ (530,691 )   $ -     $ (530,691 )
Loss from operations   $ (668,940 )   $ -     $ (668,940 )
Other Income from Change in Fair Value of Warrants   $ -     $ 342,884     $ 342,884  
Loss from continuing operations   $ (668,018 )   $ 342,884     $ (325,134 )
Net loss   $ (747,575 )   $ 342,884     $ (404,691 )
Net loss per share, basic and diluted   $ (3.59 )   $ 1.64     $ (1.95 )
                         

 

    Three Months Ended September 30, 2012  
    As Previously             As  
Statement of Operations Data (Unaudited):   Reported*     Adjustment     Restated  
                         
Selling, general and administrative expense   $ (542,538 )   $ -     $ (542,538 )
Loss from operations   $ (633,645 )   $ -     $ (633,645 )
Other Income from Change in Fair Value of Warrants   $ -     $ 58,413     $ 58,413  
Loss from continuing operations   $ (632,815 )   $ 58,413     $ (574,402 )
Net loss   $ (765,963 )   $ 58,413     $ (707,550 )
Net loss per share, basic and diluted   $ (3.69 )   $ 0.29     $ (3.40 )

 

* As retroactively adjusted for the 2012 reverse stock split and the 2012 discontinued operations

 

Impact of the Restatement

 

    Three Months Ended March 31, 2011  
    As Previously           As  
Statement of Operations Data (Unaudited):   Reported*     Adjustment     Restated  
Selling, general and administrative expense   $ (737,680 )   $ (126,304 )   $ (863,984 )
Loss from operations   $ (1,093,183 )   $ (126,304 )   $ (1,219,487 )
Other Income from Change in Fair Value of Warrants   $ -     $ 1,542,051     $ 1,542,051  
(Loss) income from continuing operations   $ (216,819 )   $ 1,415,747     $ 1,198,928  
Net (loss) income   $ (235,336 )   $ 1,415,747     $ 1,180,411  
Net (loss) income per share, basic and diluted   $ (1.92 )   $ 11.56     $ 9.64  

 

    Three Months Ended June 30, 2011  
    As Previously             As  
Statement of Operations Data (Unaudited):   Reported*     Adjustment     Restated  
Selling, general and administrative expense   $ (525,572 )   $ (- )   $ (525,572 )
Loss from operations   $ (930,071 )   $ -     $ (930,071 )
Other Income from Change in Fair Value of Warrants   $ -     $ 898,446     $ 898,446  
Loss from continuing operations   $ (920,828 )   $ 898,446     $ (22,382 )
Net loss   $ (1,013,739 )   $ 898,446     $ (115,293 )
Net loss per share, basic and diluted   $ (7.91 )   $ 7.01     $ (0.90 )
                         

 

    Three Months Ended September 30, 2011  
    As Previously             As  
Statement of Operations Data (Unaudited):   Reported*     Adjustment     Restated  
Selling, general and administrative expense   $ (417,260 )   $ (- )   $ (417,260 )
Loss from operations   $ (788,587 )   $ -     $ (788,587 )
Other Income from Change in Fair Value of Warrants   $ -     $ 134,827     $ 134,827  
Loss from continuing operations   $ (787,992 )   $ 134,827     $ (653,165 )
Net loss   $ (913,318 )   $ 134,827     $ (778,491 )
Net loss per share, basic and diluted   $ (7.13 )   $ 1.05     $ (6.08 )

 

* As retroactively adjusted for the 2012 reverse stock split and the 2012 discontinued operations

 

Impact of the Restatement

 

    Year Ended December 31, 2011  
    As Previously           As  
Statement of Operations Data:   Reported*     Adjustment     Restated  
Selling, general and administrative expense   $ (2,317,403 )   $ (230,604 )   $ (2,548,007 )
Loss from operations   $ (3,963,342 )   $ (230,604 )   $ (4,193,946 )
Other Income from Change in Fair Value of Warrants   $ -     $ 3,716,812     $ 3,716,812  
Loss on issuance of warrants   $ -     $ (4,983 )   $ (4,983 )
Income (loss) from continuing operations   $ (3,078,111 )   $ 3,481,225     $ 403,114  
Net (loss) income   $ (3,461,640 )   $ 3,481,225     $ 19,585  
Net (loss) income per share, basic   $ (26.37 )   $ 26.52     $ 0.15  
Net (loss) income per share, diluted   $ (26.37 )   $ 21.23     $ (5.14

 

    Year Ended December 31, 2010  
    As Previously             As  
Statement of Operations Data:   Reported*     Adjustment     Restated  
Selling, general and administrative expense   $ (3,175,350 )   $ (165,365 )   $ (3,340,715 )
Loss from operations   $ (8,006,738 )   $ (165,365 )   $ (8,172,103 )
Other Income from Change in Fair Value of Warrants   $ -     $ 1,556,161     $ 1,556,161  
Loss from continuing operations   $ (7,731,521 )   $ 1,390,796     $ (6,340,725 )
Net loss   $ (7,736,242 )   $ 1,390,796     $ (6,345,446 )
Net loss per share, basic and diluted   $ (85.67 )   $ 15.40     $ (70.27 )

 

    Year Ended December 31, 2009  
    As Previously             As  
Statement of Operations Data:   Reported     Adjustment     Restated  
Selling, general and administrative expense   $ (3,055,473 )   $ (136,752 )   $ (3,192,225 )
Loss from operations   $ (9,877,082 )   $ (136,752 )   $ (10,013,834 )
Other Income from Change in Fair Value of Warrants   $ -     $ 957,422     $ 957,422  
Loss from continuing operations   $ (9,839,436 )   $ 820,670     $ (9,018,766 )
Net loss   $ (9,148,631 )   $ 820,670     $ (8,327,961 )
Net loss per share, basic and diluted   $ (124.36 )   $ 11.16     $ (113.20 )

 

* As retroactively adjusted for the 2012 reverse stock split and the 2012 discontinued operations

 

Impact of the Restatement

 

    As of March 31, 2012  
    As Previously           As  
Balance Sheet Data (Unaudited):   Reported*     Adjustment     Restated  
Total liabilities   $ 639,097     $ 791,601     $ 1,430,698  
Paid-in capital in excess of par value   $ 43,394,988     $ (6,805,964 )   $ 36,589,024  
Accumulated deficit   $ 38,302,840     $ (6,014,363 )   $ 32,288,477  
Total stockholders' equity   $ 4,627,383     $ (791,601 )   $ 3,835,782  

 

    As of June 30, 2012  
    As Previously             As  
Balance Sheet Data (Unaudited):   Reported*     Adjustment     Restated  
Total liabilities   $ 679,960     $ 448,717     $ 1,128,677  
Paid-in capital in excess of par value   $ 43,401,195     $ (6,805,964 )   $ 36,595,231  
Accumulated deficit   $ 39,050,415     $ (6,357,247 )   $ 32,693,168  
Total stockholders' equity   $ 3,886,015     $ (448,717 )   $ 3,437,298  

 

    As of September 30, 2012  
    As Previously             As  
Balance Sheet Data (Unaudited):   Reported*     Adjustment     Restated  
Total liabilities   $ 793,960     $ 389,913     $ 1,183,873  
Paid-in capital in excess of par value   $ 43,420,333     $ (6,805,964 )   $ 36,614,369  
Accumulated deficit   $ 39,816,415     $ (6,415,697 )   $ 33,400,718  
Total stockholders' equity   $ 3,139,190     $ (390,304 )   $ 2,748,886  

 

* As retroactively adjusted for the 2012 reverse stock split

 

Impact of the Restatement

 

    As of March 31, 2011  
    As Previously           As  
Balance Sheet Data (Unaudited):   Reported*     Adjustment     Restated  
Total liabilities   $ 818,816     $ 1,826,897     $ 2,645,713  
Paid-in capital in excess of par value   $ 41,135,829     $ (5,454,110 )   $ 35,681,719  
Accumulated deficit   $ 33,920,581     $ (3,627,213 )   $ 30,293,368  
Total stockholders' equity   $ 6,750,475     $ (1,826,897 )   $ 4,923,578  

 

    As of June 30, 2011  
    As Previously             As  
Balance Sheet Data (Unaudited):   Reported*     Adjustment     Restated  
Total liabilities   $ 741,041     $ 928,451     $ 1,669,492  
Paid-in capital in excess of par value   $ 41,135,586     $ (5,454,110 )   $ 35,681,476  
Accumulated deficit   $ 34,934,320     $ (4,525,659 )   $ 30,408,661  
Total stockholders' equity   $ 5,736,493     $ (928,451 )   $ 4,808,042  

 

    As of September 30, 2011  
    As Previously             As  
Balance Sheet Data (Unaudited):   Reported*     Adjustment     Restated  
Total liabilities   $ 807,153     $ 793,624     $ 1,600,777  
Paid-in capital in excess of par value   $ 41,135,586     $ (5,454,110 )   $ 35,681,476  
Accumulated deficit   $ 35,847,638     $ (4,660,486 )   $ 31,187,152  
Total stockholders' equity   $ 4,823,175     $ (793,624 )   $ 4,029,551  

 

    As of December 31, 2011  
    As Previously             As  
Balance Sheet Data:   Reported*     Adjustment     Restated  
Total liabilities   $ 940,357     $ 916,621     $ 1,856,978  
Paid-in capital in excess of par value   $ 42,326,320     $ (6,609,312 )   $ 35,717,008  
Accumulated deficit   $ 37,146,885     $ (5,692,691 )   $ 31,454,194  
Total stockholders' equity   $ 4,714,665     $ (916,621 )   $ 3,798,044  

 

* As retroactively adjusted for the 2012 reverse stock split

 

Impact of the Restatement

 

    As of December 31, 2010  
    As Previously           As  
Balance Sheet Data (Unaudited):   Reported*     Adjustment     Restated  
Total liabilities   $ 2,576,853     $ 1,841,826     $ 4,418,679  
Paid-in capital in excess of par value   $ 38,590,239     $ (4,053,292 )   $ 34,536,947  
Accumulated deficit   $ 33,685,245     $ (2,211,466 )   $ 31,473,779  
Total stockholders' equity   $ 4,440,219     $ (1,841,826 )   $ 2,598,393  

 

    As of December 31, 2009  
    As Previously             As  
Balance Sheet Data (Unaudited):   Reported*     Adjustment     Restated  
Total liabilities   $ 2,883,432     $ 1,128,278     $ 4,969,132  
Paid-in capital in excess of par value   $ 33,685,656     $ (1,948,948 )   $ 31,736,708  
Accumulated deficit   $ 25,949,003     $ (820,670 )   $ 25,128,333  
Total stockholders' equity   $ 7,271,876     $ (1,128,278 )   $ 6,143,598  

 

* As retroactively adjusted for the 2012 and 2011 reverse stock splits